Publicaciones
Publicaciones Científicas del Dr. Pascual Izuel
Impact of abdominal obesity and ambulatory blood pressure in the diagnosis of left ventricular hypertrophy in never treated hypertensives. Med Clin (Barc). 2014 Mar 20;142(6):235-42. doi: 10.1016/j.medcli.2013.04.046. Epub 2013 Oct 16. PubMed PMID: 24139053. Cited in PMC Related citations
Regression
of left ventricular hypertrophy and microalbuminuria changes during
antihypertensive treatment. J Hypertens.
2013 Aug;31(8):1683-91. doi: 10.1097/HJH.0b013e328361461e. PubMed PMID:
23835910. Cited in PMC Related citations
Investigators of Resistant Hypertension Registry of
the Spanish Society of Hypertension. Increased
pulse pressure is associated with left atrial enlargement in resistant
hypertensive patients. Blood Press. 2013 Feb;22(1):39-44.
doi: 10.3109/08037051.2012.701789. PubMed PMID: 23305454. Related citations
Relationship of central and peripheral blood pressure to left
ventricular mass in hypertensive patients. Rev Esp
Cardiol (Engl Ed). 2012 Dec;65(12):1094-100. doi: 10.1016/j.recesp.2012.05.008.
Epub 2012 Aug 27. English, Spanish. PubMed PMID: 22951089. Related citations
Metabolic
Syndrome as a marker of cardiovascular events in hypertensives in primary
prevention. Med Clin (Barc). 2012 Jul
7;139(4):150-6. doi: 10.1016/j.medcli.2011.05.018. Epub 2011 Aug 2. Spanish.
PubMed PMID: 21813141. Related citations
DYSIS investigators. Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study. Diabet Med. 2011 Nov;28(11):1343-51. doi: 10.1111/j.1464-5491.2011.03360.x. PubMed PMID: 21679231. Cited in PMC Related citations
Grupo de Investigadores del Registro de Hipertensión
refractaria de la Sociedad Española de Hipertensión/Liga Española para la Lucha
contra la Hipertensión Arterial (SEH-LELHA). Prevalence
of target organ damage and metabolic abnormalities in resistant hypertension. Med Clin (Barc). 2011 Oct 15;137(10):435-9. doi:
10.1016/j.medcli.2011.02.035. Epub 2011 Jun 29. Spanish. PubMed PMID: 21719041. Cited in PMC
Related citations
Spanish Society of Hypertension-Resistant Hypertension
Registry. Urinary
albumin excretion is associated with nocturnal systolic blood pressure in
resistant hypertensives. Hypertension.
2011 Mar;57(3):556-60. doi: 10.1161/HYPERTENSIONAHA.110.165563. Epub 2011 Jan
10. PubMed PMID: 21220713. Cited in PMC Related citations
Relationship
between increased arterial stiffness and other markers of target organ damage. Med Clin (Barc). 2010 Apr 24;134(12):528-33. doi:
10.1016/j.medcli.2009.09.042. PubMed PMID: 20022065. Cited in PMC Related citations
LDL-cholesterol
goals and changes in C reactive protein in high coronary risk patients. Rev Clin Esp. 2009 Oct;209(9):415-23. Spanish. PubMed PMID: 19852909. Related citations
Spironolactone
and doxazosin treatment in patients with resistant hypertension. Rev Esp Cardiol. 2009 Feb;62(2):158-66. English, Spanish. PubMed PMID:
19232189. Cited in PMC Related citations
Association
between serum uric acid, metabolic syndrome and microalbuminuria in previously
untreated essential hypertensive patients. Med Clin
(Barc). 2009 Jan 17;132(1):1-6. doi: 10.1016/j.medcli.2008.07.008. Epub 2008
Dec 3. PubMed PMID: 19174057. Cited in PMC Related citations
Body
weight variation and control of cardiovascular risk factors in essential
hypertension. Blood Press. 2009;18(5):247-54.
doi: 10.3109/08037050903244791. PubMed PMID: 19919395. Cited in PMC Related citations
Spironolactone
in patients with resistant hypertension. Med Clin
(Barc). 2008 Oct 4;131(11):406-11. Spanish. PubMed PMID: 18928720. Related citations
Added
impact of obesity and insulin resistance in nocturnal blood pressure elevation
in children and adolescents. Hypertension.
2008 Mar;51(3):635-41. doi: 10.1161/HYPERTENSIONAHA.107.099234. Epub 2008 Jan
14. PubMed PMID: 18195166. Cited in PMC Related citations
Cystatin
C and other cardiovascular markers in hypertension. Med Clin (Barc). 2008 Jan 19;130(1):1-5. Spanish. PubMed PMID:
18221636. Cited in PMC Related citations
Predictors
of nosocomial infection in acute stroke. Relation with morbimortality and
outcome. Med Clin (Barc). 2007 Mar
31;128(12):441-7. Spanish. PubMed PMID: 17408536. Cited in PMC Related citations
New
definition of metabolic syndrome: does it have the same cardiovascular risk? Rev Clin Esp. 2007 Feb;207(2):69-74. Spanish. PubMed PMID: 17397565. Cited in PMC Related citations
Determinants of urinary albumin excretion reduction in essential hypertension: A long-term follow-up study. J Hypertens. 2006 Nov;24(11):2277-84. PubMed PMID: 17053551. Cited in PMC Related citations
Lipid lowering goals in high risk and very high cardiovascular risk patients: a reasonable challenge? Rev Clin Esp. 2006 Oct;206(9):417-21. Spanish. PubMed PMID: 17042982. Cited in PMC Related citations
Indications
of efficacy of bariatric surgery in the management of morbid obesity. Rev Clin Esp. 2006 Sep;206(8):385-7. Spanish. PubMed PMID: 16863624. Related citations
Impact
of metabolic syndrome on CRP levels. Rev Clin Esp.
2006 Sep;206(8):363-8. Spanish. PubMed PMID: 16863620. Related citations
Development
of microalbuminuria in essential hypertension. Curr Hypertens Rep. 2006 May;8(2):171-7. Review. PubMed PMID: 16672152. Cited in PMC Related citations
Cardiovascular
risk by Framingham and SCORE in patients 40-65 years old. Med Clin (Barc). 2006 Apr 15;126(14):527-31. Spanish. PubMed PMID:
16756903. Cited in PMC Related citations
C-reactive
protein changes with antihypertensive and statin treatment. Med Clin (Barc). 2005 Oct 29;125(15):561-4. Spanish. PubMed PMID:
16277947. Related citations
Long-term
impact of systolic blood pressure and glycemia on the development of
microalbuminuria in essential hypertension. Hypertension.
2005 Jun;45(6):1125-30. Epub 2005 May 16. PubMed PMID: 15897369. Cited in PMC Related citations
Impact
of metabolic syndrome in the control of blood pressure and dyslipemia. Med Clin (Barc). 2004 Nov 6;123(16):601-5. Spanish. PubMed PMID:
15546516. Related citations
Polymorphisms of the angiotensinogen gene and the outcome of microalbuminuria in essential hypertension: a 3-year follow-up study. J Hum Hypertens. 2004 Jan;18(1):25-31. PubMed PMID: 14688807. Related citations
Clinical use of statins and cholesterol goals in patients with several cardiovascular risk factors. Med Clin (Barc). 2003 Oct 25;121(14):527-31. Spanish. PubMed PMID: 14599407. Related citations
Factors
related to the occurrence of microalbuminuria during antihypertensive treatment
in essential hypertension. Hypertension.
2002 Mar 1;39(3):794-8. PubMed PMID: 11897766. Cited in PMC Related citations
Factors
associated with changes in microalbuminuria during antihypertensive treatment. Med Clin (Barc). 2000 May 20;114(19):721-5. Spanish. PubMed PMID:
10919124. Related citations
Insertion/deletion
polymorphism of the gene encoding for angiotensin-converting enzyme and
microalbuminuria in essential arterial hypertension. Med Clin (Barc). 1999 May 29;112(19):726-30. Spanish. PubMed PMID:
10394569. Related citations
Ambulatory
arterial pressure and left ventricular hypertrophy in untreated hypertensive
patients. Med Clin (Barc). 1999 Feb
13;112(5):166-70. Spanish. PubMed PMID: 10091209. Cited in PMC Related citations
Treatment
of community-acquired pneumonia in outpatients: randomized study of
clarithromycin alone versus clarithromycin and cefuroxime. Respiration. 1999;66(5):413-8. PubMed PMID: 10516537.Cited in PMC Related citations
Prognostic
value of ambulatory blood pressure monitoring in refractory hypertension: a
prospective study. Hypertension. 1998 Feb;31(2):712-8.
PubMed PMID: 9461245. Cited in PMC Related citations
Influence
of the I/D polymorphism of the angiotensin-converting enzyme gene on the
outcome of microalbuminuria in essential hypertension. Hypertension. 2000 Jan;35(1 Pt 2):490-5. PubMed PMID: 10642347. Cited in PMC Related citations